ClinicalTrials.Veeva

Menu
K

Kyiv Regional Oncological Dispensary | Kyiv, Ukraine

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Alectinib
Darolutamide
Prednisone Versus Abiraterone Acetate
Estrogen
Niraparib
Prednisone
Giredestrant
Abiraterone Acetate
Crizotinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 4 total trials

A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants (ALEX)

This randomized, active controlled, multicenter phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Alectinib
Drug: Crizotinib

This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant giredestrant compared with end...

Enrolling
Early Breast Cancer
Drug: Endocrine Therapy of Physician's Choice
Drug: Abemaciclib

The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus predniso...

Active, not recruiting
Metastatic Castration-sensitive Prostate Cancer
Drug: Niraparib
Drug: Prednisone
Locations recently updated

The purpose of the study is to assess the efficacy and safety of darolutamide in combination with standard androgen deprivation therapy (ADT) in pati...

Active, not recruiting
Prostatic Neoplasms
Other: Androgen deprivation therapy (ADT)
Drug: Placebo

Trial sponsors

Roche logo
Bayer logo
Janssen (J&J Innovative Medicine) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems